Too few booster doses: Moderna plunges on the stock market
Too few booster doses: Moderna plunges on the stock marketDigital Dawn - 20 Sep 2023
Moderna plunges after Pfizer finds only 24% of Americans seek anti-covid booster doses.
The shares of mRNA manufacturer Moderna – best known for being one of the main sponsors of the US Open tournament, won by Novak Djokovic, who was not vaccinated and was unable to participate in the tournament in due to its refusal to succumb to Moderna's product alone and Democratic brainwashing – fell 9%, the biggest intraday decline since August 7, making it the worst performer on the S&P500 and Nasdaq 100. Aug. 7, making it the worst performer on the S&P500 and Nasdaq 100, after rival drugmaker Pfizer released forecasts for how many Americans are likely to get the recently approved Covid-19 vaccine. And yes, shares of Pfizer and BioNTech also fell.
